You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

All-trans retinoic acid

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Trial (all trans Retinoic Acid, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • all trans Retinoic Acid
  • +2 more
  • (no location specified)
Aug 11, 2023

Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

Recruiting
  • Acute Promyelocytic Leukemia
  • +2 more
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Apr 26, 2023

Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)

Completed
  • Effect of Drug
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Jul 28, 2022

Melanoma Trial in Aurora (VESANOID, Ipilimumab)

Active, not recruiting
Has Results
  • Melanoma
  • Aurora, Colorado
    University of Colorado Hospital
Sep 7, 2022

Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)

Not yet recruiting
  • Glioma
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 22, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 27, 2022

APL Trial in Shanghai (Chidamide+venetoclax)

Active, not recruiting
  • APL
  • Shanghai, Shanghai, China
    Jiong HU
May 30, 2023

Multiple Myeloma Trial in Amsterdam (all-trans retinoic acid (ATRA))

Active, not recruiting
  • Multiple Myeloma
  • all-trans retinoic acid (ATRA)
  • Amsterdam, NH, Netherlands
    VU University Medical Center
May 5, 2022

Prostatic Tumors, Prostate Tumors, Prostate Cancer Trial in New York (5-Azacitidine, all trans retinoic acid, Lupron)

Completed
  • Prostatic Neoplasms
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 1, 2022

Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)

Recruiting
  • Promyelocytic Leukemia
  • Arsenic trioxide
  • all-trans retinoic acid
  • Monterrey, Nuevo Leon, Mexico
    Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Aug 9, 2022

Acute Myeloid Leukemia Trial in Xi'an (All-trans retinoic acid, Arsenic Trioxide, Realgar-Indigo naturalis formula)

Recruiting
  • Acute Myeloid Leukemia
  • All-trans retinoic acid
  • +2 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Mar 23, 2022

Cholangitis, Sclerosing Trial in New Haven (All-trans retinoic acid)

Terminated
Has Results
  • Cholangitis, Sclerosing
  • All-trans retinoic acid
  • New Haven, Connecticut
    Yale University
Aug 4, 2021

Adenoid Cystic Carcinoma Trial in Boston (Tretinoin)

Completed
Has Results
  • Adenoid Cystic Carcinoma
  • Boston, Massachusetts
  • +1 more
Jul 15, 2021

Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)

Recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
    John Theurer Cancer Center
Jun 10, 2022

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic

Not yet recruiting
  • Tuberculosis
  • 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
  • +5 more
  • Cairo, Kafr El-sheikh, Egypt
  • +1 more
Oct 11, 2021

Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)

Not yet recruiting
  • Purpura, Thrombocytopenic, Idiopathic
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jun 25, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Adelaide (IMG-7289, All-trans retinoic acid)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Adelaide, South Australia, Australia
    Royal Adelaide Hospital
Jan 24, 2022

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Recruiting
  • Promyelocytic Leukemia, Adult Acute
  • Evaluation of first line treatment with ATO/ATRA outcome
  • Caba, Argentina
  • +1 more
Nov 9, 2021

Breast Cancer Female Trial (All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone)

Not yet recruiting
  • Breast Cancer Female
  • All trans-retinoic acid
  • +6 more
  • (no location specified)
Aug 17, 2021

Immune Thrombocytopenia Trial in Beijing (Dexamethasone, ATRA)

Completed
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Sep 22, 2021

Adenoid Cystic Carcinoma of the Head and Neck Trial in Shanghai (All-trans Retinoic Acid, VEGFR inhibitor, Chemotherapy)

Recruiting
  • Adenoid Cystic Carcinoma of the Head and Neck
  • All-trans Retinoic Acid
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital
Jan 31, 2021

Acute Myeloid Leukemia Trial in United States (TAS1440, TAS1440 + ATRA)

Recruiting
  • Acute Myeloid Leukemia
  • Tucson, Arizona
  • +8 more
Jan 3, 2023

Post COVID-19 Anosmia (Loss of Smell) Trial in Foshan, Kafr Ash Shaykh, Riyadh (Aerosolized 13 cis retinoic acid plus Vitamin D,

Not yet recruiting
  • Post COVID-19 Anosmia (Loss of Smell)
  • Aerosolized 13 cis retinoic acid plus Vitamin D
  • +2 more
  • Foshan, Guangdong, China
  • +2 more
Nov 9, 2021

the Lung Complication of COVID-19 Trial (Aerosolized All-Trans Retinoic acid plus oral Tamoxifen, Standard treatment)

Unknown status
  • the Lung Complication of COVID-19
  • Aerosolized All-Trans Retinoic acid plus oral Tamoxifen
  • Standard treatment
  • (no location specified)
Oct 23, 2020